Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone

Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
Aug 4, 2026, 7:22:31 AM
3
min read
Isto Biologics Announces New Leadership Transition

Isto Biologics Announces New Leadership Transition
Oct 2, 2025, 1:59:59 PM
3
min read
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners

Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Sep 17, 2025, 9:08:36 AM
3
min read
